APA (7th ed.) Citation

N, C., C, P., P, M., BL, C., MG, T., M, C., . . . MC, P. (2024). Cryptosporidium lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy. Science translational medicine, 16(770), eadm8631. https://doi.org/10.1126/scitranslmed.adm8631

Chicago Style (17th ed.) Citation

N, Caldwell, et al. "Cryptosporidium Lysyl-tRNA Synthetase Inhibitors Define the Interplay Between Solubility and Permeability Required to Achieve Efficacy." Science Translational Medicine 16, no. 770 (2024): eadm8631. https://doi.org/10.1126/scitranslmed.adm8631.

MLA (9th ed.) Citation

N, Caldwell, et al. "Cryptosporidium Lysyl-tRNA Synthetase Inhibitors Define the Interplay Between Solubility and Permeability Required to Achieve Efficacy." Science Translational Medicine, vol. 16, no. 770, 2024, p. eadm8631, https://doi.org/10.1126/scitranslmed.adm8631.